Dr Maria Alfredsson leading efforts to develop an aqueous battery as part of a Mylogic led collaboration for developing sensors for diseases including Covid-19.
Dr Maria Alfredsson has recently secured funding to develop a battery utilising an aqueous battery for powering a sensor capable of detecting diseases, including Covid-19.
Maria comments “the development of environmentally sustainable energy solutions includes removing organic solvents in batteries, leaving us with aqueous electrolytes. Aqueous batteries also have improved safety properties making them suitable to mass produce for applications in health devices. In collaboration with the EDA, and Whistonbrook Ltd we have been approached by Mologic Ltd to develop a demonstrator to test for various diseases, such as COVID-19. As part of the test device the SPS has been instructed to develop an aqueous battery with specific properties. The funding to the SPS is £213k (total funding £400k).”
Well done and congratulations to Maria for continuing to lead MEE group efforts in cutting edge battery technologies.